experiments 5.1. 2. Behavioral and biochemical evidence 5.2. Interaction with the glutamatergic system 5.2. 1. Regulation of NMDA receptors 5.2. 2. Ascorbate-glutamate- dopamine interactions 6. Clinical implications
5.1. Interaction with the dopaminergic system 5.1. 1. Dopamine receptor binding experiments 5.1. 2. Behavioral and biochemical evidence 5.2. Interaction with the glutamatergic system 5.2. 1. Regulation of NMDA receptors 5.2. 2. Ascorbate-glutamate-dopamine interactions 6. Clinical implications